HPND (N = 20) | HTG (N = 30) | HPD (N = 5) | P | |
---|---|---|---|---|
TC | 6.36 ± 2.53 | 6.75 ± 1.58 | 8.66 ± 6.86 | NS |
TG | 2.67 (1.85–5.00) | 4.81 (2.57–7.83) | 13.32 (7.69–29.77) | 0.006* |
VLDL-Chol | 0.78 ± 0.41 | 0.91 ± 0.49 | 0.98 ± 0.59 | NS |
HDL-Chol | 1.01 ± 0.47 | 0.91 ± 0.39 | 0.39 ± 0.13 | 0.01* |
LDL-Chol | 3.21 ± 1.40 | 3.39 ± 1.32 | 1.45 ± 1.27 | 0.01 * |
VLDL-TG | 1.27 (1.02–1.81) | 1.39 (1.07–2.49) | 1.94 (1.45–3.22) | NS |
HDL-TG | 0.35 (0.28–0.46) | 0.32 (0.25–0.46) | 0.21 (0.14–0.44) | NS |
LDL-TG | 0.56 (0.39–0.64) | 0.53 (0.43–0.69) | 0.59 (0.46–1.00) | NS |
Chylo-Chol | 2.95 ± 3.34 | 2.22 ± 1.58 | 5.90 ± 7.55 | NS |
Chylo-TG | 3.31 (2.52–7.40) | 3.48 (2.21–6.60) | 8.49 (5.2–23.81) | 0.02** |
Apo A-I | 1.14 ± 0.29 | 1.11 ± 0.28 | 0.54 ± 0.17 | <0.001 * |
Apo B-100 | 0.98 ± 0.27 | 0.98 ± 0.25 | 0.56 ± 0.37 | 0.007 * |
Apo CII | 0.11 ± 0.06 | 0.13 ± 0.07 | 0.09 ± 0.05 | NS |
Apo CIII | 0.17 ± 0.07 | 0.20 ± 0.09 | 0.19 ± 0.05 | NS |
Apo E | 0.07 ± 0.04 | 0.11 ± 0.06 | 0.14 ± 0.03 | 0.005 * |
CIII/CII | 2 ± 3 | 1.7 ± 0.7 | 5 ± 7 | NS |
LPLactivity (mU/ml) | 82 ± 34 | 95 ± 41 | 0.4 ± 0.5 | <0.001 * |
HL-activity (mU/ml) | 179 ± 95 | 195 ± 86 | 107 ± 47 | NS |
Posth-LPLmass (ng/ml) | 365 ± 164 | 422 ± 190 | 58 ± 27 | <0.001* |
Preh-LPLmass (ng/ml) | 19 ± 10 | 22 ± 14 | 17 ± 12 | NS |